Aletaha, D. & Smolen, J. S. Diagnosis and management of rheumatoid arthritis: a review. JAMA 320, 1360–1372 (2018).
Gravallese, E. M. & Firestein, G. S. Rheumatoid arthritis—common origins, divergent mechanisms. N. Engl. J. Med. 388, 529–542 (2023).
Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623, 616–624 (2023).
Fearon, U., Hanlon, M. M., Floudas, A. & Veale, D. J. Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications. Nat. Rev. Rheumatol. 18, 398–414 (2022).
Buckley, C. D., Ospelt, C., Gay, S. & Midwood, K. S. Location, location, location: how the tissue microenvironment affects inflammation in RA. Nat. Rev. Rheumatol. 17, 195–212 (2021).
Weyand, C. M. & Goronzy, J. J. Immunometabolism in early and late stages of rheumatoid arthritis. Nat. Rev. Rheumatol. 13, 291–301 (2017).
Boutet, M. A. et al. Novel insights into macrophage diversity in rheumatoid arthritis synovium. Autoimmun. Rev. 20, 102758 (2021).
Martel-Pelletier, J. et al. Osteoarthritis. Nat. Rev. Dis. Prim. 2, 16072 (2016).
Burmester, G. R. & Pope, J. E. Novel treatment strategies in rheumatoid arthritis. Lancet 389, 2338–2348 (2017).
Nissen, S. E. et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N. Engl. J. Med. 375, 2519–2529 (2016).
Erhardt, D. P. et al. Low persistence rates in patients with rheumatoid arthritis treated with triple therapy and adverse drug events associated with sulfasalazine. Arthritis Care Res. 71, 1326–1335 (2019).
Zhu, Y. et al. Rheumatoid arthritis microenvironment insights into treatment effect of nanomaterials. Nano Today 42, 101358 (2022).
Nizet, V. & Johnson, R. S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609–617 (2009).
Zhao, Y. et al. Nanozyme-reinforced hydrogel as a H2O2-driven oxygenerator for enhancing prosthetic interface osseointegration in rheumatoid arthritis therapy. Nat. Commun. 13, 6758 (2022).
Zhang, Q. et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 13, 1182–1190 (2018).
Jia, M. et al. Messenger nanozyme for reprogramming the microenvironment of rheumatoid arthritis. ACS Appl. Mater. Interfaces 15, 338–353 (2023).
Kim, J. et al. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano 13, 3206–3217 (2019).
Yang, Y. et al. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials 264, 120390 (2021).
Yang, J., Yang, B. & Shi, J. A nanomedicine-enabled ion-exchange strategy for enhancing curcumin-based rheumatoid arthritis therapy. Angew. Chem. Int. Ed. 62, e202310061 (2023).
Xu, C. et al. Arthritic microenvironment actuated nanomotors for active rheumatoid arthritis therapy. Adv. Sci. 10, e2204881 (2023).
Chen, J. et al. Photoacoustic image-guided biomimetic nanoparticles targeting rheumatoid arthritis. Proc. Natl Acad. Sci. USA 119, e2213373119 (2022).
Koo, S. et al. Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model. Nat. Nanotechnol. 18, 1502–1514 (2023).
Del Giudice, G. et al. An ancestral molecular response to nanomaterial particulates. Nat. Nanotechnol. 18, 957–966 (2023).
Stater, E. P., Sonay, A. Y., Hart, C. & Grimm, J. The ancillary effects of nanoparticles and their implications for nanomedicine. Nat. Nanotechnol. 16, 1180–1194 (2021).
Gao, J. et al. Intracerebral fate of organic and inorganic nanoparticles is dependent on microglial extracellular vesicle function. Nat. Nanotechnol. 19, 376–386 (2024).
Li, Y. et al. Innate immunity-modulating nanobiomaterials for controlling inflammation resolution. Matter 7, 3811–3844 (2024).
Zhang, M. et al. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials 101, 321–340 (2016).
Chen, Q. et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm. Sin. B 12, 907–923 (2022).
Feng, T., Ahmed, W., Ahmed, T. & Chen, L. Nanoparticles derived from herbal preparations may represent a novel nucleic acid therapy. Interdiscip. Med. 2, e20230029 (2024).
Miller, T. E. et al. Light-powered CO2 fixation in a chloroplast mimic with natural and synthetic parts. Science 368, 649–654 (2020).
Gao, F. et al. Artificial photosynthetic cells with biotic–abiotic hybrid energy modules for customized CO2 conversion. Nat. Commun. 14, 6783 (2023).
Hou, L. et al. Hybrid-membrane-decorated Prussian blue for effective cancer immunotherapy via tumor-associated macrophages polarization and hypoxia relief. Adv. Mater. 34, e2200389 (2022).
Suk, J. S., Xu, Q., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99, 28–51 (2016).
Kobayashi, K., Jimbo, H., Nakamura, Y. & Wada, H. Biosynthesis of phosphatidylglycerol in photosynthetic organisms. Prog. Lipid Res. 93, 101266 (2024).
Pali, T., Garab, G., Horvath, L. I. & Kota, Z. Functional significance of the lipid-protein interface in photosynthetic membranes. Cell. Mol. Life Sci. 60, 1591–1606 (2003).
Liu, J. et al. Delivery of biomimetic liposomes via meningeal lymphatic vessels route for targeted therapy of Parkinson’s disease. Research 6, 0030 (2023).
Hao, M. et al. Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Sci. Transl. Med. 12, eaaz6667 (2020).
Barber, J. A mechanism for water splitting and oxygen production in photosynthesis. Nat. Plants 3, 17041 (2017).
Kafri, M. et al. Systematic identification and characterization of genes in the regulation and biogenesis of photosynthetic machinery. Cell 186, 5638–5655.25 (2023).
Hald Albertsen, C. et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv. Drug Deliv. Rev. 188, 114416 (2022).
Chen, P. et al. A plant-derived natural photosynthetic system for improving cell anabolism. Nature 612, 546–554 (2022).
Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295–1306 (2020).
Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Prim. 4, 18001 (2018).
Lan, R. et al. Folate receptor-targeted NIR-II dual-model nanoprobes for multiscale visualization of macrophages in rheumatoid arthritis. Adv. Func. Mat. 33, 2300342 (2023).
Ma, Y. et al. DNA origami as a nanomedicine for targeted rheumatoid arthritis therapy through reactive oxygen species and nitric oxide scavenging. ACS Nano 16, 12520–12531 (2022).
Hegarty, L. M., Jones, G. R. & Bain, C. C. Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 20, 538–553 (2023).
Venkatesan, R. et al. Immuno-modulating theranostic gold nanocages for the treatment of rheumatoid arthritis in vivo. Chem. Eng. J. 446, 136868 (2022).
Tardito, S. et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmun. Rev. 18, 102397 (2019).
Liu, Y. et al. Multifunctional Janus nanoplatform for efficiently synergistic theranostics of rheumatoid arthritis. ACS Nano 17, 8167–8182 (2023).
You, D. G. et al. Metabolically engineered stem cell–derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis. Sci. Adv. 7, eabe0083 (2021).
Rodriguez-Ramiro, I. et al. Pharmacological and genetic increases in liver NADPH levels ameliorate NASH progression in female mice. Free Radic. Biol. Med. 210, 448–461 (2024).
Weng, L. et al. Surplus fatty acid synthesis increases oxidative stress in adipocytes and lnduces lipodystrophy. Nat. Commun. 15, 133 (2024).
Fearon, U., Canavan, M., Biniecka, M. & Veale, D. J. Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nat. Rev. Rheumatol. 12, 385–397 (2016).
Jia, N. et al. Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms. Signal Transduct. Target Ther. 8, 280 (2023).
Guan, F. et al. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduct. Target Ther. 10, 93 (2025).
Wang, Z. et al. A targeted exosome therapeutic confers both CfDNA scavenging and macrophage polarization for ameliorating rheumatoid arthritis. Adv. Mater. 35, e2302503 (2023).
Li, L. et al. M2 macrophage-derived sEV regulate pro-inflammatory CCR2+ macrophage subpopulations to favor post-AMI cardiac repair. Adv. Sci. 10, e2202964 (2023).
Qiao, Y. et al. Engineered algae: a novel oxygen-generating system for effective treatment of hypoxic cancer. Sci. Adv. 6, eaba5996 (2020).
Wang, W. et al. Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments. Nat. Commun. 13, 4495 (2022).
Zhong, D. et al. Microalgae-based hydrogel for inflammatory bowel disease and its associated anxiety and depression. Adv. Mater. 36, e2312275 (2024).
Ouyang, J. et al. Biomimetic nanothylakoids for efficient imaging-guided photodynamic therapy for cancer. Chem. Commun. 54, 3468–3471 (2018).
Chen, B., Ni, Y., Liu, J., Zhang, Y. & Yan, F. Bone marrow-derived mesenchymal stem cells exert diverse effects on different macrophage subsets. Stem Cells Int. 2018, 8348121 (2018).
Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445–455 (2013).
Ma, C. et al. Significantly improving the bioefficacy for rheumatoid arthritis with supramolecular nanoformulations. Adv. Mater. 33, e2100098 (2021).